Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Creapharm Establishes U.S. Subsidiary | Contract Pharma

What are you searching for?

Sign in
Breaking News

Creapharm Establishes U.S. Subsidiary

Creapharm Europe has established a U.S. subsidiary, Creapharm-MP5, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Creapharm Europe has established a U.S. subsidiary, Creapharm-MP5, Inc. Through its subsidiaries Creapharm and MP5, Creapharm Europe manufacturers cytotoxic and other high-potency drugs as well as clinical supply services.

As part of the launch, Matthew Maupin has been appointed vice president of business development, North America. Mr. Maupin’s efforts will focus on promoting MP5’s services in the U.S. and Canada with particular focus on the oncology market. He will also promote Creapharm’s clinical supply offerings.

Most recently, Mr. Maupin was the vice president of business development for a U.S. CMO. Previously held leadership positions in quality and operations in addition to owning a research reagent business focused on RNAi (RNA interference).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters